Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
anemia, assay, asserted, baseline, Canada, checkpoint, clearance, collagen, colorectal, ECM, endometrial, ensuring, esophageal, external, extracellular, fusion, greater, hepatocellular, infusion, KEYTRUDA, lymphopenia, mAb, matrix, mechanism, Merck, move, moving, MSD, Notable, proceed, rationale, refractory, remodel, resistance, stable, therapy, tissue, TME, translate, wind, worsening
Removed:
adjust, announce, anticipated, ASCO, began, carcinoma, commenced, demonstrating, distancing, driven, enroll, enrolling, exposure, half, HNSCC, immunity, Immunotherapy, Improvement, localized, lockdown, microenvironment, potentially, promoted, recommended, regimen, shelter, SITC, social, Virtual, weekly
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view